Original Research
Accepted on 27 Jun 2025
Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center, real-world experience
in Alloimmunity and Transplantation
- 154 views